Reports

Sale

United States Compounding Pharmacies Market

United States Compounding Pharmacies Market Size: By Type: Oral, Topical, Suppositories, Others; By Compounding Type: Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Others; By Sterility; By Therapeutic Area; By Distribution Channel; By Application; Competitive Landscape; 2024-2032

United States Compounding Pharmacies Market Outlook

The United States compounding pharmacies market is being driven by the rising geriatric population and growing demand from parenteral division. The market is expected to grow at a CAGR of 6% in the forecast period of 2024-2032.

 

United States Compounding Pharmacies Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Geriatric Population Boosting the Compounding Pharmacies Industry Growth

The rising geriatric demographic base, combined with increased longevity, are the primary drivers of market growth. According to the Population Reference Bureau, by 2060, the geriatric population of the United States is expected to account for about 24% of the total population. The population's longevity has risen as the birth rate has decreased and life expectancy has increased. Additionally, the industry's overall development is supported by compounding pharmacies' low costs over the forecast period. A higher percentage of consumers choose compounding pharmacies, as well as an increasing desire to look healthier and younger, has resulted in increased demand for anti-ageing drugs across the United States, consequently favouring the market growth.

 

Compounding Pharmacies:  Industry Definition and Segmentation

Compounding pharmacies refer to the on-demand distribution of computing resources over the internet, such as storage, servers, applications, and networking, to allow quicker innovation and economies of scale. Customers prefer compounding pharmacies over conventional on-premise deployments because it helps them to pay directly for the resources they need and handle their technology more effectively.

 

United States Compounding Pharmacies Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type,  the market is divided into:

  • Oral
  • Topical
  • Suppositories
  • Others

With regards to compounding type, the market is segmented into:

  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others

On the basis of sterility, the market is bifurcated into:

  • Sterile
  • Non-sterile

By therapeutic area, the market is segregated into:

  • Pain and Management
  • Hormone Replacement Therapy (HRT)
  • Others

Based on distribution channel, the market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online 
  • Others

By application, the market is segmented into:

  • Pediatric
  • Adult
  • Geriatric
  • Veterinary
  • Others

 

United States Compounding Pharmacies Market Report and Forecast

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Parenteral Division Fostering the Growth of United States Compounding Pharmacies Industry

The widespread acceptance of compounding pharmacies services, especially public cloud, is expected to boost the market growth of compounding pharmacies in the United States. In 2020, the parenteral division accounted for 18% of the market share of compounding pharmacies in the United States. Compounding ophthalmic treatment drugs, such as glaucoma medications, lower the cost, further boosting the adoption of the product. This has invigorated the market in recent years. Furthermore, compounded dose formulations such as glaucoma reductions assist elderly patients in reducing individual pressure as well as uncertainty about multiple drugs and dosing schedules, thus favouring retail value. Ophthalmic drugs may be administered in a variety of ways, including oral pills, capsules, injections, and drops. As a result, the increasing availability of multiple dosage types in ophthalmic treatment is expected to propel the segment forward. This is predicted to contribute to the overall market growth over the forecast period.

 

Key Industry Players in the United States Compounding Pharmacies Market

The report gives a detailed analysis of the following key players in the United States compounding pharmacies market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Fagron N.V.
  • PharMedium Services, LLC
  • Fresenius Kabi Canada
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Compounding Type
  • Sterility
  • Therapeutic Area
  • Distribution Channel
  • Application
Breakup by Type
  • Oral
  • Topical
  • Suppositories
  • Others
Breakup by Compounding Type
  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others
Breakup by Sterility
  • Sterile
  • Non-sterile
Breakup by Therapeutic Area
  • Pain Management
  • Hormone Replacement Therapy (HRT)
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others
Breakup by Application
  • Pediatric
  • Adult
  • Geriatric 
  • Veterinary 
  • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Fagron N.V.
  • PharMedium Services, LLC
  • Fresenius Kabi Canada
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    United States
7    Opportunities and Challenges in the Market
8    United States Compounding Pharmacies Market Analysis

    8.1    Key Industry Highlights
    8.2    United States Compounding Pharmacies Historical Market (2018-2023) 
    8.3    United States Compounding Pharmacies Market Forecast (2024-2032)
    8.4    United States Compounding Pharmacies Market by Type
        8.4.1    Oral
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Topical
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Suppositories
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
        8.4.4    Others
    8.5    United States Compounding Pharmacies Market by Compounding Type
        8.5.1    Pharmaceutical Ingredient Alteration (PIA)
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Currently Unavailable Pharmaceutical Manufacturing (CUPM)
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Pharmaceutical Dosage Alteration (PDA)
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Others
    8.6    United States Compounding Pharmacies Market by Sterility
        8.6.1    Sterile
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Non-sterile 
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
    8.7    United States Compounding Pharmacies Market by Therapeutic Area
        8.7.1    Pain Management
            8.7.1.1    Historical Trend (2018-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Hormone Replacement Therapy (HRT)
            8.7.2.1    Historical Trend (2018-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Others
    8.8    United States Compounding Pharmacies Market by Distribution Channel
        8.8.1    Hospital Pharmacies
            8.8.1.1    Historical Trend (2018-2023)
            8.8.1.2    Forecast Trend (2024-2032)
        8.8.2    Retail Pharmacies
            8.8.2.1    Historical Trend (2018-2023)
            8.8.2.2    Forecast Trend (2024-2032)
        8.8.3    Online
            8.8.3.1    Historical Trend (2018-2023)
            8.8.3.2    Forecast Trend (2024-2032)
        8.8.4    Others
    8.9    United States Compounding Pharmacies Market by Application
        8.9.1    Pediatric
            8.9.1.1    Historical Trend (2018-2023)
            8.9.1.2    Forecast Trend (2024-2032)
        8.9.2    Adult
            8.9.2.1    Historical Trend (2018-2023)
            8.9.2.2    Forecast Trend (2024-2032)
        8.9.3    Geriatric 
            8.9.3.1    Historical Trend (2018-2023)
            8.9.3.2    Forecast Trend (2024-2032)
        8.9.4    Veterinary 
            8.9.4.1    Historical Trend (2018-2023)
            8.9.4.2    Forecast Trend (2024-2032)
        8.9.5    Others
9    Market Dynamics
    9.1    SWOT Analysis
        9.1.1    Strengths
        9.1.2    Weaknesses
        9.1.3    Opportunities
        9.1.4    Threats
    9.2    Porter’s Five Forces Analysis
        9.2.1    Supplier’s Power
        9.2.2    Buyer’s Power
        9.2.3    Threat of New Entrants
        9.2.4    Degree of Rivalry
        9.2.5    Threat of Substitutes
    9.3    Key Indicators for Demand
    9.4    Key Indicators for Price
10    Value Chain Analysis
11    Competitive Landscape

    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Fagron N.V.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    PharMedium Services, LLC
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Fresenius Kabi Canada
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Others
12    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    United States Compounding Pharmacies Market: Key Industry Highlights, 2018 and 2032
2.    United States Compounding Pharmacies Historical Market: Breakup by Product (USD Billion), 2018-2023
3.    United States Compounding Pharmacies Market Forecast: Breakup by Product (USD Billion), 2024-2032
4.    United States Compounding Pharmacies Historical Market: Breakup by Compounding Type (USD Billion), 2018-2023
5.    United States Compounding Pharmacies Market Forecast: Breakup by Compounding Type (USD Billion), 2024-2032
6.    United States Compounding Pharmacies Historical Market: Breakup by Sterility (USD Billion), 2018-2023
7.    United States Compounding Pharmacies Market Forecast: Breakup by Sterility (USD Billion), 2024-2032
8.    United States Compounding Pharmacies Historical Market: Breakup by Therapeutic Area (USD Billion), 2018-2023
9.    United States Compounding Pharmacies Market Forecast: Breakup by Therapeutic Area (USD Billion), 2024-2032
10.    United States Compounding Pharmacies Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
11.    United States Compounding Pharmacies Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
12.    United States Compounding Pharmacies Historical Market: Breakup by Application (USD Billion), 2018-2023
13.    United States Compounding Pharmacies Market Forecast: Breakup by Application (USD Billion), 2024-2032
14.    United States Compounding Pharmacies Market Structure

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 6% between 2024 and 2032.

The major drivers of the market are expansion of compounding pharmacies in the country, increasing prevalence of chronic health conditions, easy handling, and low costs of compounding pharmacies.

The key trends influencing the market include the rising geriatric population, increasing costs of doctor visits, and growing availability of multiple dosage types.

Compounding pharmacies are types of pharmacies that are able to dispense combinations of medications for custom requirements of patients.

The significant applications of compounding pharmacies are pediatric, adult, geriatric, and veterinary, among others.

The major distribution channels in the market are hospital pharmacies, retail pharmacies, and online, among others. 

The primary therapeutic areas are pain management, and hormone replacement therapy (HRT), among others.

The various compounding types in the market are pharmaceutical ingredient alteration (PIA), currently unavailable pharmaceutical manufacturing (CUPM), and pharmaceutical dosage alteration (PDA), among others.

Types of compounding pharmacies are oral, topical, and suppositories, among others.

The major players in the United States compounding pharmacies market are Fagron N.V., PharMedium Services, LLC, and Fresenius Kabi Canada, among others.

Purchase Full Report

Mini Report

$ 1999     $1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3999     $3699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6299     $5699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 8499     $7699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER